Key Record Dates
ClinicalTrials.gov Identifier: | NCT04136353 |
---|---|
Brief Title: | Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP) |
First Submitted : | October 17, 2019 |
First Submitted that Met QC Criteria : | October 21, 2019 |
First Posted : | October 23, 2019 |
Last Update Submitted that Met QC Criteria : | July 26, 2023 |
Last Update Posted : | July 28, 2023 |